Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer. J Clin Oncol 1995; 13: 1860–70Langer CJ, Leighton J, McAleer C, et al: Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer. Semin Oncol 22:64-69, 1995...
(FDA MedWatch definition) when the patient outcome is: death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent impairment or damage Sixteen women aged 39-81 years developed haematological toxicity during treatment with carboplatin and paclitaxel for ...
when the patient outcome is: death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent impairment or damage A 60-year-old woman developed peripheral arterial thrombosis during postoperative chemotherapy with carboplatin and paclitaxel for ovarian and endometrial...
Indications of Carboplatin and Paclitaxel The combination of Carboplatin and Paclitaxel usually works better than a single drug. It is approved for treatment: Cancer of unknown primary origin Cancer of the cervix Endometrial cancer Non-small cell lung cancer Ovarian cancer. Advanced and untreated thymom...
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic brea... Homologous recombination defects in BRCA1/2-mutated tumors result in sensitivity to poly(ADP-ribose) polymerase (PARP) inhibitors, which interfere ...
Paclitaxel/carboplatin was given a category 2B designation. Non-Small cell lung cancer: routine CT screening nixed Today, first-line standard therapy includes tumor debulking surgery (removal of all visible tumors), followed by six cycles of combination Paclitaxel/carboplatin administered intravenously eve...
Objective The current study intended to determine the incidence, severity and reversibility of paclitaxel plus carboplatin (CP)-induced peripheral neuropathy CPPN) and to describe its clinical and electrophysiological features. Patients and methods We prospectively studied 21 adult patients sc...
Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I do... Marks LB,Garst J,Socinski MA, et al.Carboplatin/Paclitaxel or Carboplatin/ Vinorelbine followed by accelerated hyperfractionated conformal radiation ...
Related articles And Qustion Carboplatin and Paclitaxel: Indications and Side Effects Sep 9, 2024See also What is Ganciclovir? Feb 10, 2020 What is Ruxolitinib phosphate? Feb 10, 2020Lastest Price from Carboplatin manufacturers CisplatinUS $120.00/kg2025-02-21 CAS: 41575-94-4 Min. Order: 1kg ...
METHODS Thirty-eight patients with previously untreated small cell lung carcinoma were treated with a combination regimen including paclitaxel, 135 mg/m2 by 1-hour intravenous (i.v.) infusion, on Day 1; carboplatin at AUC 5, on Day 1; and oral etoposide, 100 mg alternated with 50 mg, on...